• ISSN 2399-1623

Volume 1

Journal of Global Health Reports’ Mission Statement: "Promoting Local Research to Improve Global Health"

01 June 2017
J Glob Health Rep 2017; 1: e2017001

In comparison to many other fields of science, global health research has many specific features that may require different approaches to publishing. Although research in glob al health issues clearly requires a remarkable effort from researchers, and can have a very large translational impact on society, policies and decision-making, many journals are reluctant to publish work from local contexts. The lack of general relevance or interest, typically small sample sizes and low likelihood that the work would be cited by many other scientists are the likely explanations for this rather unfortunate situation. This led us to launch the Journal of Global Health Reports – to embrace local research on difficult questions and issues in global health. This journal should become a platform for publishing research from challenging contexts, offering an opportunity to publish papers in flexible formats and styles. The journal will also embrace all instruments of research – epidemiological research, health policy and systems research, research focused on the improvement of the existing interventions, as well as research that proposes to develop new and innovative interventions. We are also entirely open to all methodological approaches – qualitative, quantitative and mixed methods, or even descriptive reports or personal insights and thoughts on what we feel are relevant problems in global health.

HTML PDF (2 pages)

Globalisation and health: a blessing or a curse? Case review of the Indian health system

01 December 2017
J Glob Health Rep 2017; 1: e2017004

Examination of the healthcare system in India and in particular the disparities in access to health services that exist between the rural poor and the urban rich and the impact that the increasing privatisation of health services is having on these populations. The article also considers the impact of medical tourism on the changing landscape of health services in the country and whether the benefits of this trickle-down to the poor.

HTML PDF (6 pages)

To what extent is abortion legislation a key challenge for health equity in Northern Ireland?

01 December 2017
J Glob Health Rep 2017; 1: e2017005

It is unlikely that the debate on abortion in Northern Ireland will soon reach a conclusion, as there is still significant political and religious unrest in the country. For women and medical practitioners to feel safe under the current law, there must be some clarification on its interpretation in practice. Increased pressure to release the official guidelines is, therefore, a matter of priority. In addition, the recent ruling that Northern Irish women must pay for abortion services in England means that there is significant health inequity between those who have the money to travel and pay for private care and those that do not. This is further compounded by the difficulty some women face when trying to access services abroad when they suffer social stigma and pressure. For this inequity to be addressed in any real sense, it is imperative that Stormont and Westminster look again at this issue and either make treatment free through the mainland NHS, subsidize women’s costs of travel and treatment, or change the law such that women are able to access abortion and reproductive services more readily. Through addressing important related factors at a grass-roots level, it may be possible, in time, for Northern Ireland to bring itself back into line with the rest of the UK on this issue and ensure equity for women’s reproductive rights.

HTML PDF (5 pages)

Not PrEPared to wait any longer: Advocating for the use of PrEP in a HIV prevention strategy

01 December 2017
J Glob Health Rep 2017; 1: e2017006

Pre-exposure prophylaxis (PrEP) is a protective measure in the form of a pill (Brand name Truvuda), taken to reduce the chance of contracting HIV sexually. WHO guidelines currently recommend that oral PrEP should be offered as an additional prevention choice for people at substantial risk of HIV infection, as part of combination HIV prevention approaches. This paper advocates for the use of PrEP in clinical practice in a UK setting to reduce transmission rates amongst men who have sex with men (MSM). I discuss the evidence surrounding the effectiveness of treatment and some of the potential parallel benefits and costs of treatment, as well as some of the cost implications for a health system. I argue that we should move beyond current HIV strategies offered to MSM and that PrEP should be available in the framework of a HIV prevention strategy

HTML PDF (5 pages)

Pandemic influenza: preparing for an uncertain inevitability

29 November 2017
J Glob Health Rep 2017; 1: e2017003

When it comes to pandemic influenza, the question is not “if”, but “when” this will occur. There has been substantial progress from the GAP over the past 10 years, and the world is more prepared than ever for an influenza pandemic. Nonetheless, there remain significant challenges to ensure there is sufficient and timely vaccine production and distribution to effectively respond when the next emerges.

HTML PDF (2 pages)

The global threat of antibiotic resistance: what can be done?

17 November 2017
J Glob Health Rep 2017; 1: e2017002

In addition to treating bacterial infections, antibiotics guard against infections. Antibiotics make surgical operations possible, promote the survival of premature babies, and enable immunosuppression (e.g. cancer chemotherapy). With an ageing and increasingly overweight global population, chronic illnesses treated surgically (e.g. hip replacements) may become very hazardous without effective antibiotics. Due to antibiotic misuse and a lack of successful development of new antibiotics, antibiotic resistance is an increasing global threat. In this overview, I address the problem of the global threat of antibiotic resistance through following sections: A brief history of antibiotics; What are antibiotics used for?; How does antibiotic resistance develop?; How does antibiotic resistance spread?; Why is resistance becoming a problem?; Why are there no new antibiotics?; How bad is the problem?; and What can we do?

HTML PDF (8 pages)